Want to know more about Leukemia or Blood cancer? Here’s something you can readily go through in just few seconds.
Find much information on Leukemia its origin, causes, incidence and the research statistics details.
Leukemia or Blood cancer literally means ‘many white cells in the blood’.
As you know White blood cells are produced by the bone marrow, the soft spongy centre of bones. They then pass from the bone marrow into the blood stream and lymph system.
White blood cells are involved in various functions of the immune system which is the body’s defense system.
This immune system protects the body from infections. In Leukemia or Blood cancer, some blood cells do not grow properly, but remain within the bone marrow and continue to reproduce in an uncontrolled way.
Strange! These cells fill up the bone marrow and prevent it from making healthy white blood cells. This means the body is less able to fight off infections.
Also the bone marrow is able to make other types of blood cells, such as red blood cells and platelets. Problems can result from a reduction in number of these cells.
For example, a lack of red blood cells leads to anemia, which can result in breathlessness and fatigue. A lack of platelets can lead to problems with the blood-clotting system, resulting in bruising.
Leukemia is the most common cancer in children, but cancer is generally rare in children, and also affects nine times as many adults as children
Alert! If you notice tiredness (due to anemia), bruising easily (often without having had any blow or fall), weight loss, night sweats, fever, repeated infections remember all these symptoms are as well common for Leukemia too.
So better be very watchful and consult a doctor without any negligence to avoid further complications.
A number of new therapies, including a proteasome inhibitor, a monoclonal antibody and radioimmunotherapies, have recently been developed for the treatment of lymphoma and multiple myeloma.
Although these treatments represent important advances for lymphoma and myeloma patients, the patients still have inadequate treatment options and face a difficult prognosis.
Research!! Recent strides in the fight against Leukemias are the result of substantial public and private investments in cooperation and research and among private foundations like the National Institutes of Health (NIH), academic researchers, and the pharmaceutical and biotechnology industries.
All parties to the research enterprise must be engaged in cooperative ventures. In order to accelerate the development of new therapies, we must adopt innovative and aggressive strategies that not only build on, but surpass past collaborations. Good right!
Incidence and Survival! While the incidence and survival numbers for many forms of cancer have improved, and officials cite them as evidence of significant progress against cancer, the numbers for lymphoma and myeloma are much different.
Please note that Leukemia is the second among cancers in mortality and fifth in incidence. The challenging situation for Leukemia patients can only be addressed through bold action on the research front. Be Bold and Fight Back!